All News ARYA Sciences Acquisition Corp IV

Equities

ARYD

KYG316591083

Market Closed - Nasdaq Other stock markets 21:30:00 25/04/2024 BST			5-day change	1st Jan Change
11.33 ^USD	-0.18%		+0.18%	+3.94%

03-29	ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-08	ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
ARYA Sciences Acquisition IV : Failure to Satisfy Listing Rule - Form 8-K	03-29	PU
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies	02-14	PR
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	02-07	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K	03/10/23	PU
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding from ARYA Sciences Holdings IV	26/09/23	CI
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K	05/09/23	PU
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K	02/08/23	PU
ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination	03/07/23	GL
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV	01/06/23	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
ARYA SCIENCES ACQUISITION CORP IV Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	06/04/23	AQ
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022	06/04/23	CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt	05/04/23	CI
ARYA Sciences Acquisition IV : Non-Reliance on Previously Issued Financial Report - Form 8-K	05/04/23	PU
ARYA SCIENCES ACQUISITION CORP IV : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	05/04/23	AQ
ARYA SCIENCES ACQUISITION CORP IV : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	01/03/23	AQ
ARYA Sciences Acquisition Corp IV announced that it expects to receive $1.68 million in funding from ARYA Sciences Holdings IV	27/02/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ARYA Sciences Acquisition Corp IV

Equities

ARYD

KYG316591083

All News

Filters